N-acetylcysteine
N-acetylcysteine is a pharmaceutical drug with 178 clinical trials. Currently 16 active trials ongoing. Historical success rate of 84.9%.
Success Metrics
Based on 107 completed trials
Phase Distribution
Phase Distribution
39
Early Stage
59
Mid Stage
49
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.7%
107 of 131 finished
18.3%
24 ended early
16
trials recruiting
178
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Oral N-acetylcysteine for Retinitis Pigmentosa
Clinical Trials (178)
Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Oral N-acetylcysteine for Retinitis Pigmentosa
Assessment of the Impact of N-acetylcysteine Supplementation on Physical Performance
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
A Study of N-acetylcysteine in Patients With COVID-19 Infection
Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Therapeutics for Moderate and Severe Dengue
Effects of NAC on Symptoms of CHR Patients
Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Tolerability of Enteral NAC in Infants
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 178